Medicine and Dentistry
Epidermal Growth Factor Receptor
100%
Anti-Epidermal Growth Factor Receptor
80%
Patient
80%
Monoclonal Antibody
60%
Epidermal Growth Factor Receptor Antibody
60%
Biological Marker
40%
Antibody Dependent Cellular Cytotoxicity
40%
Immunoglobulin G1
40%
Cetuximab
40%
Antibody Therapy
40%
Cell Proliferation
20%
Neoplasm
20%
Combination Therapy
20%
Protein Tyrosine Kinase
20%
Cell Survival
20%
Solid Malignant Neoplasm
20%
Cell Motility
20%
Panitumumab
20%
Gene
20%
PTEN (Gene)
20%
Therapeutic Procedure
20%
Analysis
20%
Mitogen-Activated Protein Kinase
20%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Monoclonal Antibody
60%
Epidermal Growth Factor Receptor Antibody
60%
Biological Marker
40%
Cetuximab
40%
Immunoglobulin G1
40%
Metastatic Colorectal Cancer
40%
Neoplasm
20%
Panitumumab
20%
Solid Malignant Neoplasm
20%
Protein Tyrosine Kinase
20%
Colorectal Cancer
20%